NJ Vindicator

Sandoz reaches $400 million settlement in generic drug price-fixing case

New Jersey and 42 other states and territories accused the generic drugmaker of conspiring with competitors to inflate prices and limit competition.

Read the original at NJ Vindicator

More audio from NJ Vindicator